Primer: Shield Therapeutics (STX LN) - Aug 2026
Shield Therapeutics is a single-product commercial-stage pharmaceutical company, with its success entirely dependent on the market adoption of...
93 Views
𝛼SK or SearchENTITY
Shield Therapeutics (STX LN)
Shield Therapeutics (STX LN)
47
Analysis
Health Care • United Kingdom
Shield Therapeutics is a commercial-stage specialty pharmaceutical company focused on pharmaceuticals for unmet medical needs. Its primary product, Accrufer/Feraccru (ferric maltol), is an oral therapy for iron deficiency with or without anemia. The company was founded in 2008 and is headquartered in Gateshead, United Kingdom.
morex